20 results on '"Heney, N.M."'
Search Results
2. Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA
3. Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer
4. Multimodality Management in Primary Urethral Cancer: The Role of Radiation Therapy
5. Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233
6. Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer
7. Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels
8. Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience
9. Defining Biochemical Control After Prostate Brachytherapy: Can We Use a Target PSA?
10. Organ conservation as an alternative to radical cystectomy for invasive bladder cancer: urodynamic and quality of life evaluation of patients treated by trimodality therapy
11. RTOG 9706: initial report of a phase I/II trial of bladder-conservation employing TURB, accelerated irradiation sensitized with Cisplatin followed by adjuvant MCV chemotherapy
12. Selective bladder preservation by combined modality treatment of invasive bladder cancer: 10-Year outcome
13. 41 : A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy
14. 42 A phase trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis
15. 2018 Selective bladder preservation by combined modality therapy for invasive bladder cancer
16. 1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA
17. 7 Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
18. Results of a randomized trial of total radiation for stage T3-T4 prostate cancer boosting with photons (to 67.2 cge) or with conformal protons (to 75.6 CGE)
19. Post-irradiation biopsy of the prostate in stage T3 prostatc cancer: Correlation with original histologic grade and with current PSA values
20. Invasive bladder cancer: MCV (methotrexate, cisplatin, vinblastine) followed by cisplatin plus pelvic irradiation and possible cystectomy: Patient tolerance and local tumor response
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.